Study of ibrexafungerp safety during pregnancy
Part of Infections, Mouth & dental, Women’s health & pregnancy clinical trials.
This study looks at what happens when ibrexafungerp is taken during pregnancy, including outcomes for the baby. You may join if you were exposed to this medicine during pregnancy (or very close to conception) and you agree to share information and complete study follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were exposed to ibrexafungerp during pregnancy
- OR conception likely happened within 4 days after your last ibrexafungerp dose
- You can provide consent (you or your legal representative) to join the study
- You can do pregnancy testing if needed (a positive urine test confirms pregnancy for this study)
- You can give accurate medical history and allow medical record sharing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the safety of a medicine called elafibranor when taken before or during pregnancy. Researchers want to understand how the medicine affects pregnant people and their babies to help keep both safe.
This study tracks the safety of odevixibat (a liver medicine) in women who took it during pregnancy or while breastfeeding. It helps patients and doctors understand if the medicine poses any risks.
This registry study tracks outcomes for mothers with inflammatory bowel disease (IBD) and their babies during pregnancy and breastfeeding while using IBD medicines. It aims to better understand the safety of these medicines so future pregnancies can be managed more confidently.
This study is a registry that collects information from pregnant people with inflammatory bowel disease. By joining, you help researchers understand how IBD and treatments affect pregnancy and baby health.
This study looks at how safe certain IBD medications are when taken during pregnancy and while breastfeeding. It follows mothers and their babies to check for any health effects.
This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.
Hear when a new Vulvovaginal Candidiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.